Avid Bioservices, Inc. announced that it has posted an investor presentation regarding its pending acquisition by GHO Capital Partners and Ampersand Capital Partners. The transaction offers Avid ...
TUSTIN, Calif., Jan. 08, 2025 (GLOBE NEWSWIRE) -- Avid Bioservices, Inc. (NASDAQ: CDMO) (“Avid” or the “Company”), a dedicated biologics contract development and manufacturing organization (“CDMO”) ...
(MENAFN- GlobeNewsWire - Nasdaq) Avid Urges Stockholders to Vote FOR the Pending Transaction TODAY TUSTIN, Calif., Jan. 08, 2025 (GLOBE NEWSWIRE) -- Avid Bioservices, Inc. (NASDAQ: CDMO) (“Avid” or ...